Takeda's QDENGA becomes first dengue vaccine approved in India
Takeda's QDENGA becomes first dengue vaccine approved in India July 20 (Reuters) - Japanese drugmaker Takeda Pharmaceutical's 4502.T dengue vaccine QDENGA has been approved by India's drug regulator, making it the first dengue vaccine to be approved in the country, the company's Indian unit said on Monday.
(Reporting by Rishika Sadam; Editing by Janane Venkatraman)
Recent news on Takeda Pharmaceutical
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics tumbles below IPO price
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom (updated)